Mitochondria specific highly cytoselective iridium(iii)–Cp* dipyridophenazine (dppz) complexes as cancer cell imaging agents-Reference-Cited by-同舟云学术

Mitochondria specific highly cytoselective iridium(iii)–Cp* dipyridophenazine (dppz) complexes as cancer cell imaging agents

Published:2021 Issue:6 Volume:50 Page:2268-2283
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Roy Nilmadhab¹²³⁴⁵,Sen Utsav⁶⁷⁸⁹⁵,Ray Chaudhuri Shreya¹²³⁴⁵,Muthukumar Venkatesan¹²³⁴⁵,Moharana Prithvi⁶⁷⁸⁹⁵,Paira Priyankar¹²³⁴⁵^ORCID,Bose Bipasha⁶⁷⁸⁹⁵,Gauthaman Ashna¹⁰¹¹⁵,Moorthy Anbalagan¹⁰¹¹⁵

Affiliation:

1. Department of Chemistry

2. School of Advanced Sciences

3. VIT

4. Vellore-632014

5. India

6. Stem Cells and Regenerative Medicine Centre

7. Yenepoya Research Centre Yenepoya University

8. University Road

9. Mangalore 575018

10. School of Bioscience and Technology

11. Vellore Institute of Technology

Abstract

We have developed target specific, highly cytoselective, lipophilic and water soluble iridium(iii)–Cp* dipyridophenazine (dppz) cancer theranostic drugs.

Funder

Department of Science and Technology, Ministry of Science and Technology, India

VIT University

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/DT/D0DT03586F

Reference50 articles.

1. The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials

2. Bioactive iridium and rhodium complexes as therapeutic agents